AETHLON MEDICAL INC
Filed Aug 20, 2025.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Aug 20, 2025
Contents
Special Note Regarding Forward-Looking Statements
This prospectus and the documents incorporated herein by reference contain forward-looking statements. The forward-looking statements are contained principally in the sections entitled “Summary,” “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Business” in this prospectus or the documents incorporated herein by reference. These statements relate to future events or to our future financial performance and involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements include, but are not limited to, statements about:
| · | our ability to successfully commercialize our products and technology, including our Hemopurifier; |
| · | our ability to raise additional capital to meet our working capital needs; |
| · | the timing and results of future clinical trials; |
| · | our ability to successfully complete our clinical trials; |
| · | our ability to identify and work with large-scale contracts with medical device manufacturers; |
| · | our ability to manufacture the Hemopurifier; |
| · | the impact of inflation, recent bank failures and military conflicts, as well as related political and economic responses on our business; |
| · | our ability to attract and retain executive management and directors; |
| · | the regulatory landscape for our products, domestically and internationally and our ability to comply with changing government regulations; |
| · | our ability to comply with the continued listing requirements of the Nasdaq Capital Market and maintain our listing on the Nasdaq Capital Market; |
| · | our expectations regarding growth potential for our business in the organ transplant setting; |
| · | our ability to secure regulatory clearance or approval, domestically and internationally, for the clinical use of our products; |
| · | any estimates regarding expenses, future revenue and capital requirements; |
| · | our ability to protect our proprietary technology through patent protection; |
| · | our product liability exposure; |
| · | our ability to sustain and manage growth, including our ability to develop new products and enter new markets; |
| · | our ability to achieve sufficient market acceptance of any of our products or product candidates; and |
| · | our expected net proceeds from this offering and the use of the net proceeds from this offering. |
In some cases, you can identify these statements by terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “continue,” “seek,” “project,” “should,” “will,” “would” or the negative of those terms, and similar expressions. You should be aware that the occurrence of any of the events discussed under the heading “Risk Factors” in this prospectus and any documents incorporated by reference herein could substantially harm our business, operating results and financial condition and that if any of these events occurs, it could adversely affect the value of an investment in our common stock. In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date the statement is made, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. In addition, even if our results of operations, financial condition and cash flows and the development of the markets in which we operate, are consistent with the forward-looking statements contained in this prospectus, those results or developments may not be indicative of results or developments in subsequent periods. New factors emerge from time to time that may cause our business not to develop as we expect, and it is not possible for us to predict all of them. Factors that could cause actual results and outcomes to differ from those reflected in forward-looking statements include, among others, the following:
| · | estimates of our addressable market, market growth, future revenue, expenses, capital requirements and our needs for additional financing; |
| · | the implementation of our business model and strategic plans for our products and technologies; |
| · | competitive companies and technologies and our industry; |
| · | our ability to develop and commercialize new products; |
| · | our ability to establish and maintain intellectual property protection for our products or avoid or defend claims of infringement; |
| · | the performance of third party suppliers; |
| · | our ability to hire and retain key personnel and to manage our future growth effectively; |
| · | our ability to obtain additional financing in future offerings; |
| · | the volatility of the trading price of our common stock; |
| · | our expectations regarding use of proceeds from this offering; |
| · | the potential effects of government regulation; |
| · | the impact of trade wars and global instability; and |
| · | our expectations about market trends. |
We discuss many of these risks in greater detail under the section titled “Risk Factors” in this prospectus and in our Annual Report on Form 10-K. Given these uncertainties, you should not place undue reliance on these forward-looking statements.
You should carefully read this prospectus, the documents that we incorporate by reference into this prospectus and the documents we reference in this prospectus and have filed as exhibits to the registration statement, of which this prospectus is a part, completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of the forward-looking statements in this prospectus by these cautionary statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.